라트비아 - 라트비아어 - Zāļu valsts aģentūra

egis pharmaceuticals plc, hungary - vortioksetīns - apvalkotā tablete - 20 mg

라트비아 - 라트비아어 - Zāļu valsts aģentūra

sun pharmaceutical industries europe b.v., netherlands - lopinavirum, ritonavirum - apvalkotā tablete - 200 mg/50 mg

라트비아 - 라트비아어 - Zāļu valsts aģentūra

sandoz d.d., slovenia - lopinavirum, ritonavirum - apvalkotā tablete - 200 mg/50 mg

라트비아 - 라트비아어 - Zāļu valsts aģentūra

ranbaxy uk ltd., united kingdom - lopinavirum, ritonavirum - apvalkotās tabletes - 100 mg/25 mg

라트비아 - 라트비아어 - Zāļu valsts aģentūra

orion corporation, finland - tamoksifēns - tablete - 20 mg

라트비아 - 라트비아어 - Zāļu valsts aģentūra

olainfarm, as, latvia - amantadīna hidrohlorīds - kapsula, cietā - 100 mg

라트비아 - 라트비아어 - Zāļu valsts aģentūra

teva pharma b.v., netherlands - tamoksifēna citrāts - apvalkotā tablete - 20 mg

유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - pretvīrusu līdzekļi sistēmiskai lietošanai - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 un 5. tecovirimat siga should be used in accordance with official recommendations.

유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - narkolepsija - other nervous system drugs - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

라트비아 - 라트비아어 - Zāļu valsts aģentūra

baxter latvia, sia, latvia - ciklofosfamīds - apvalkotā tablete - 50 mg